Spinal muscular atrophy type 2
Other Names for this Disease
- Chronic infantile spinal muscular atrophy
- Chronic spinal muscular atrophy
- Dubowitz disease
- Intermediate spinal muscular atrophy
- Muscular atrophy, spinal, infantile chronic form
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.
On this page
The treatment of spinal muscular atrophy type 2 (SMA II) is symptomatic. Physical therapy, occupational therapy and assistive devices (walkers, wheelchairs, etc) are generally recommended to help encourage maximum mobility and independence. These interventions may also prevent or delay scoliosis and abnormal contractions of the muscles and tendons. Some children with SMA II may have a difficult time eating enough calories to maintain a normal weight. In these cases, nutritional counseling and/or a feeding tube may become necessary. Breathing problems are also common in people affected by SMA II and may require the use of BiPAP machines or other methods of respiratory support. Some affected children may require surgery to treat scoliosis or severe cases of hip dislocation.
Last updated: 3/25/2015
- Thomas W Prior, PhD, FACMG and Barry S Russman, MD. Spinal Muscular Atrophy. GeneReviews. November 2013; http://www.ncbi.nlm.nih.gov/books/NBK1352/.
- Tsao B. Spinal Muscular Atrophy. Medscape. May 2013; http://emedicine.medscape.com/article/1181436-overview. Accessed 4/6/2015.
- Finding Treatment Information - A video developed by GARD Information Specialists that explains how you can find information about treatment for a rare disease.
- GeneReviews provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions. Click on the link to view the article on this topic.
- ClinicalTrials.gov lists trials that are studying or have studied Spinal muscular atrophy type 2. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.